AMG:ETR
Amgen Inc
401,10 €
arrow_upward
+0,31%(+1,25) 1D
20. stu, 17:35:48 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za AMG...
Otvori
397,55 €
Najviša
408,25 €
Najniža
397,55 €
Trž. kap.
235,64 mlr.
Prosj. kol.
456,00
Količina
398,00
52-tjed. najviša
438,75 €
52-tjed. najniža
267,60 €
Broj djelatnika
32 tis.
Otvori
397,55 €
Najviša
408,25 €
Najniža
397,55 €
Trž. kap.
235,64 mlr.
Prosj. kol.
456,00
Količina
398,00
52-tjed. najviša
438,75 €
52-tjed. najniža
267,60 €
Broj djelatnika
32 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
kalkine.ca
·
prije 2 sata
Amgen (NASDAQ:AMGN) Stock Today: Unusual Volume as Shares Move Lower
ad-hoc-news.de
·
prije 11 sati
Amgen stock target raised to 542 dollars by Piper Sandler
ad-hoc-news.de
·
prije 15 sati
Piper Sandler keeps Buy on Amgen stock; EUR 398.23, down 0.41%
MarketWatch
·
prije 1 dan
Amgen Inc. stock outperforms competitors despite losses on the day
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen Inc – informacije
Glavni izvršni direktorRobert A. Bradway
Zaposlenici31,5 tis.
Osnovano1980
SjedišteThousand Oaks, Kalifornija, Sjedinjene Američke Države
SektorHealth Care
Djelatnost-
Web-lokacijaamgen.com